Traditional Chinese medicine maker Bohai Pharmaceuticals has been grabbing headlines lately as well as the interest of investors. The company added five products to its offerings this month: three prescription drugs and two OTC medicines. Investor interest is piqued by ambitious Chinese government healthcare reforms that aim to make such drugs affordable to the rural poor--the majority of China's population. Article